Dimethyldienolone (developmental code name RU-2788), or 7α,17α-dimethyldienolone, also known as δ9-7α,17α-dimethyl-19-nortestosterone or as 7α,17α-dimethylestr-4,9-dien-17β-ol-3-one, is a 17α-alkylated androgen/anabolic steroid of the 19-nortestosterone group which was never marketed.[1][2] It is closely related to dimethyltrienolone, as well as to mibolerone and metribolone.[1][2] Dimethyldienolone shows high affinity for the androgen and progesterone receptors.[1][2]
Clinical data | |
---|---|
Other names | RU-2788; 7α,17α-Dimethyldienolone; Δ9-Mibolerone; δ9-7α,17α-Dimethyl-19-nortestosterone; 7α,17α-Dimethylestr-4,9-dien-17β-ol-3-one |
Drug class | Androgen; Anabolic steroid |
Identifiers | |
CAS Number | |
UNII | |
Chemical and physical data | |
Formula | C20H28O2 |
Molar mass | 300.442 g·mol−1 |
3D model (JSmol) | |
| |
|
See also
editReferences
edit- ^ a b c Delettré J, Mornon JP, Lepicard G, Ojasoo T, Raynaud JP (January 1980). "Steroid flexibility and receptor specificity". J. Steroid Biochem. 13 (1): 45–59. doi:10.1016/0022-4731(80)90112-0. PMID 7382482.
- ^ a b c Ojasoo T, Delettré J, Mornon JP, Turpin-VanDycke C, Raynaud JP (1987). "Towards the mapping of the progesterone and androgen receptors". J. Steroid Biochem. 27 (1–3): 255–69. doi:10.1016/0022-4731(87)90317-7. PMID 3695484.